UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model

PloS one, 2022-12, Vol.17 (12), p.e0278488-e0278488

2022

Volltextzugriff (PDF)

Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model

PloS one, 2022-12, Vol.17 (12), p.e0278488

2022

Volltextzugriff (PDF)

Span of spleen is associated with disability status in multiple sclerosis: a cross-sectional abdominopelvic ultrasonography study

Scientific reports, 2024-07, Vol.14 (1), p.15297-11, Article 15297

2024

Volltextzugriff (PDF)

Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.2033540-2033540

2022

Volltextzugriff (PDF)

Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient

Human vaccines & immunotherapeutics, 2021-10, Vol.17 (10), p.3481-3483

2021

Volltextzugriff (PDF)

Endoscopic clipping of a complicated esophageal perforation following pneumatic dilation for achalasia: A case study and literature review

Clinical case reports, 2022-11, Vol.10 (11), p.e6620-n/a

2022

Volltextzugriff (PDF)

Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study

BMC neurology, 2022-02, Vol.22 (1), p.64-64, Article 64

2022

Volltextzugriff (PDF)

A Randomized Controlled Clinical Trial Comparing Clinical and Radiographic Success Rates of MTA and rhBMP2 in Pulpotomy of Primary Teeth

Frontiers in dentistry, 2024, Vol.21, p.12-12

2024

Volltextzugriff (PDF)

Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity

Frontiers in immunology, 2023-02, Vol.14, p.952911-952911

2023

Volltextzugriff (PDF)

Movement Disorders Associated with COVID-19

Parkinson's disease, 2021, Vol.2021, p.3227753-11

2021

Volltextzugriff (PDF)

Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.2041945

2022

Volltextzugriff (PDF)

Multiple sclerosis in sarcoidosis patients: Two case reports

Clinical case reports, 2022-09, Vol.10 (9), p.e6332-n/a

2022

Volltextzugriff (PDF)

Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study

Multiple sclerosis and related disorders, 2021-08, Vol.53, p.103054-103054, Article 103054

Sedaghat, Nahad

2021

Volltextzugriff (PDF)

Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies

Journal of research in medical sciences, 2021-01, Vol.26 (1), p.85-85

2021

Volltextzugriff (PDF)

Revisiting the antiviral theory to explain interferon-beta's effectiveness for relapsing multiple sclerosis

Multiple sclerosis and related disorders, 2022-11, Vol.67, p.104155-104155, Article 104155

2022

Volltextzugriff (PDF)

Inducing chimeric antigen receptor (CAR) regulatory T cells in-vivo: A novel concept for a potential feasible cure of demyelinating diseases

Multiple sclerosis and related disorders, 2022-01, Vol.57, p.103341-103341, Article 103341

2022

Volltextzugriff (PDF)

Immunomodulatory drug fingolimod

PloS one, 2022-12, Vol.17 (12), p.e0278488

2022

Volltextzugriff (PDF)

The prominence of Oligoclonal Bands for clinical conversion in Radiologically isolated syndrome: 10-year follow-up study in Isfahan, Iran

Clinical neurology and neurosurgery, 2024-10, Vol.245, p.108509, Article 108509

2024

Volltextzugriff (PDF)

Effect of multiple sclerosis disease-modifying therapies on the real-world effectiveness of two doses of BBIBP-CorV (Sinopharm) vaccine

Journal of the neurological sciences, 2023-01, Vol.444, p.120518-120518, Article 120518

2023

Volltextzugriff (PDF)

Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis

Journal of neurology, neurosurgery and psychiatry, 2022-09, Vol.93 (9), p.986-994

2022

Volltextzugriff (PDF)

Re-Evaluating the Effect of Preoperative Tranexamic Acid on Blood Loss and Field Quality During Rhinoplasty: A Randomized Double-Blinded Controlled Trial

Aesthetic plastic surgery, 2022-06, Vol.46 (3), p.1314-1320

2022

Volltextzugriff (PDF)

Pure spinal multiple sclerosis: A case series of a possible new entity

Journal of neuroimmunology, 2024-08, p.578429, Article 578429

2024

Volltextzugriff (PDF)

Anxiolytic Effect of Jasmine Aromatherapy in Pediatric Dental Procedures: A Single-Blinded Randomized Placebo-Controlled Trial

Frontiers in dentistry, 2024-10

2024

Volltextzugriff (PDF)

Anti-CD20 therapies for pediatric-onset multiple sclerosis: A systematic review

Multiple sclerosis and related disorders, 2024-11, Vol.91, p.105849, Article 105849

2024

Volltextzugriff (PDF)

COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?

Multiple sclerosis and related disorders, 2021-06, Vol.51, p.102915-102915, Article 102915

2021

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(37)
Berichte
(3)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(23)
Multiple Sclerosis
(22)
Clinical Neurology
(14)
Neurosciences & Neurology
(14)
Covid-19
(13)
Humans
(13)
Sars-Cov-2
(9)
Covid-19 Vaccines
(7)
Case Report
(6)
Disease-Modifying Therapies
(5)
Immunology
(5)
Bbibp-Corv
(4)
Cohort Studies
(4)
Demyelinating Diseases
(4)
Female
(4)
Surgery
(4)
Vaccination
(4)
Adult
(3)
Biotechnology & Applied Microbiology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model

Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model

Span of spleen is associated with disability status in multiple sclerosis: a cross-sectional abdominopelvic ultrasonography study

Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse

Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient

Endoscopic clipping of a complicated esophageal perforation following pneumatic dilation for achalasia: A case study and literature review

Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study

A Randomized Controlled Clinical Trial Comparing Clinical and Radiographic Success Rates of MTA and rhBMP2 in Pulpotomy of Primary Teeth

Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity

Movement Disorders Associated with COVID-19

Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis

Multiple sclerosis in sarcoidosis patients: Two case reports

Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study

Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies

Revisiting the antiviral theory to explain interferon-beta's effectiveness for relapsing multiple sclerosis

Inducing chimeric antigen receptor (CAR) regulatory T cells in-vivo: A novel concept for a potential feasible cure of demyelinating diseases

Immunomodulatory drug fingolimod

The prominence of Oligoclonal Bands for clinical conversion in Radiologically isolated syndrome: 10-year follow-up study in Isfahan, Iran

Effect of multiple sclerosis disease-modifying therapies on the real-world effectiveness of two doses of BBIBP-CorV (Sinopharm) vaccine

Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis

Re-Evaluating the Effect of Preoperative Tranexamic Acid on Blood Loss and Field Quality During Rhinoplasty: A Randomized Double-Blinded Controlled Trial

Pure spinal multiple sclerosis: A case series of a possible new entity

Anxiolytic Effect of Jasmine Aromatherapy in Pediatric Dental Procedures: A Single-Blinded Randomized Placebo-Controlled Trial

Anti-CD20 therapies for pediatric-onset multiple sclerosis: A systematic review

COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?

Suchergebnisse filtern